Sodium Oligomannate for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Sodium Oligomannate for Health & Longevity

Created on 07/31/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

A seaweed-derived compound taken by mouth that works mainly in the gut, reshaping gut bacteria to calm brain inflammation. Approved in China in 2019 for early Alzheimer's disease, it is easy to tolerate, with side effects close to placebo. Its real benefit is unsettled, with no proven role in prevention and no reliable source outside China. (Full Review)

Protocol

Dose
900 mg/day
Only dose with controlled efficacy data
Schedule
450 mg twice daily
Morning and evening, with or without food
Form
Oral capsule
450 mg capsule, only validated formulation
Time to effect
Cognitive effect
~4 weeks
Earliest measurable improvement
Full effect
36 weeks
Effect grew over the trial period

Benefits

Contraindications
  • Pregnancy or breastfeeding
  • Children
  • Cognitive decline not properly evaluated
    •
Key Interactions
  • Bowel-altering over-the-counter agents (laxatives, antidiarrheals, antacids)
  • Microbiota-modulating supplements (probiotics, prebiotics, fermentable fibers)
  • Broad-spectrum antibiotics (amoxicillin, ciprofloxacin)
    •

Risk & Side Effects

  • High: Gastrointestinal disturbances
    •
  • Medium: Unverified efficacy and risk of foregoing established care
    •
  • Low: Nausea and other mild adverse events
    •
  • Speculative: Unknown long-term consequences of sustained microbiome modulation
    •

Monitoring

Marker Target Why
ADAS-Cog or MMSE Stable or improved from baseline Primary measure of whether cognition is holding
Vitamin B12 > 500 pg/mL Rules out a reversible cause of cognitive decline
TSH 0.5–2.0 mIU/L Rules out thyroid-driven cognitive slowing
Fasting glucose / HbA1c HbA1c < 5.4% Metabolic health strongly influences brain aging
Complete blood count and comprehensive metabolic panel Within normal limits General safety and to detect other contributors

Cadence: Reassess at 4 weeks, 12 weeks, then every 3–6 months

Qualitative Assessment

  • Day-to-day memory and word-finding as reported by the person and caregivers
  • Ability to perform daily activities (managing finances, medications, routines)
  • Mood, engagement, and behavioral stability
  • Sleep quality and daytime alertness
  • Caregiver-observed overall trajectory
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.